Individuals infected by the hepatitis C virus (HCV) have nothing to fear from sex in a monogamous, heterosexual relationship. Transmission of HCV from an infected partner during sex is rare according to new research published ...
Mar 19, 2013
0
0
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among ...
Mar 19, 2013
0
0
(Medical Xpress)—Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.
Mar 12, 2013
0
0
Combating the tobacco industry's tactics in the world's poorest countries as well as ensuring the best cancer vaccines are available to those most in need are key in order to reduce the number of cancer deaths worldwide, ...
Mar 7, 2013
0
0
(HealthDay)—Skin changes, including new rash, new growths, discoloration, and changes in texture, could be among the first signs indicating an underlying medical condition, according to information presented at the annual ...
Mar 1, 2013
0
0
Giving inmates drug substitution treatment, needles and condoms are key ways to help curb addiction and HIV infection in European jails, experts say, calling on authorities to change their approach to prison health care.
Mar 1, 2013
0
0
(HealthDay)—Individuals who are coinfected with HIV and hepatitis C virus (HCV) exhibit liver fibrosis similar to that of individuals without HIV who are nearly 10 years older, according to research published online Feb. ...
Feb 27, 2013
0
0
A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its ...
Feb 18, 2013
0
0
(AP)—Chinese state media say 95 people have been hospitalized after a private clinic gave them injections suspected to be contaminated with hepatitis C.
Feb 5, 2013
0
0
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are ...
Jan 30, 2013
0
0
